Myovant Sciences Ltd., is a Bermuda exempted company limited by shares with registration number 51163. Its registered office is Clarendon House, 2 Church Street, Hamilton HM 11, Bermuda. The Issuer is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for women’s health and endocrine diseases.
The Issuer’s common shares are publicly traded and listed on the New York Stock Exchange under the symbol “MYOV”. The Notes will be fully and unconditionally guaranteed, on a secured basis, by each of the Issuer's wholly owned subsidiaries Myovant Holdings Limited, Myovant Sciences, Inc., Myovant Sciences GmbH, and Myovant Sciences Ireland Limited (the “Guarantors”).
TRADING HOURS | LOCATION |
---|---|
08:30-09:00 Price Discovery | Exchange House |
09:00-16:30 Continuous Trading | 110 Pitts Bay Road |
Pembroke, Bermuda | |
CONTACT DETAILS | MAILING ADDRESS |
TEL: +1 (441) 292 7212 | P.O. Box HM 1369 |
FAX: +1 (441) 292 7619 | Hamilton HMFX |
Contact Us (info@bsx.com) |
DISCLAIMER |
---|
The information contained in these pages has been obtained from sources which The Bermuda Stock Exchange believes are reliable. However, the accuracy of the information cannot and is not guaranteed and The Bermuda Stock Exchange makes no representation as to its accuracy or completeness. Neither this Web site, nor any information contained herein, constitutes advice or a solicitation to subscribe, purchase or sell any securities. The Bermuda Stock Exchange expressly disclaims any liability whatsoever for any loss howsoever arising from or in reliance upon any part of the contents of this site or any external sites referenced from this website. |